Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
897.40
|
|
Change (%)
|
32.30 (3.73%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
844.00
-
908.35
|
|
52-Week Range (RS)
|
285.80
-
950.00
|
|
Beta (1 Year)
|
0.93
|
|
|
|
|
|
| News |
|
Corporate Details |
| Venus Remedies consolidated net profit rises 30.51% in the December 2025 quarter |
| Venus Remedies to hold board meeting |
| Venus Remedies receives marketing authorisation for Ceftazidime + Avibactam in Indonesia |
| Venus Remedies consolidated net profit rises 473.50% in the September 2025 quarter |
| Venus Remedies Ltd leads gainers in 'B' group |
| Venus Remedies to convene board meeting |
| Venus Remedies Ltd - Venus Remedies Limited - Updates |
| Venus Remedies Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
| Venus Remedies Ltd - Venus Remedies Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018 ... |
|
|
|
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
27-Mar-2026 |
869.05 |
3.26 |
| 1Month |
02-Mar-2026 |
650.60 |
37.93 |
| 3Month |
02-Jan-2026 |
782.25 |
14.72 |
| 6Month |
03-Oct-2025 |
462.45 |
94.05 |
| 1Year |
02-Apr-2025 |
311.25 |
188.32 |
|
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
3,989.10 |
-2.91 |
4,479.70 |
3,101.00 |
135,009.27 |
| Ajanta Pharma Ltd |
2,795.05 |
-0.93 |
3,158.20 |
2,022.05 |
34,920.13 |
| Gland Pharma Ltd |
1,689.95 |
-0.98 |
2,130.00 |
1,200.00 |
27,843.01 |
| ERIS Lifesciences Ltd |
1,330.20 |
1.41 |
1,909.55 |
1,187.10 |
18,428.98 |
| Rubicon Research Ltd |
774.45 |
-0.76 |
887.95 |
571.00 |
12,759.09 |
|
|
|
|